Summary
IDEXX LABORATORIES, INC. (IDXX) announced on June 18, 2014, that it entered into an amended and restated unsecured revolving credit facility. This new agreement significantly increases the company's borrowing capacity to $700 million, with an option to extend it further to $850 million, compared to the previous $450 million facility. The maturity date has also been extended to June 18, 2019, providing a longer-term funding source. This expanded credit facility is a positive signal for investors, indicating IDEXX's financial strength and flexibility. The increased availability of funds can support ongoing operations, strategic investments, potential acquisitions, or share repurchases. The unsecured nature of the facility suggests strong creditworthiness and favorable terms with lenders, which is crucial for maintaining financial health and pursuing growth opportunities.
Key Highlights
- 1IDEXX entered into an amended and restated unsecured revolving credit facility on June 18, 2014.
- 2The new credit facility has a principal amount of $700 million, a substantial increase from the previous $450 million facility.
- 3The maturity date for the credit facility has been extended to June 18, 2019, providing a five-year term.
- 4The company has the option to increase the aggregate commitments by an additional $150 million, potentially bringing the total to $850 million.
- 5Borrowings under the facility are available for general corporate purposes of IDEXX and its subsidiaries.
- 6The agreement includes customary affirmative, negative, and financial covenants, with a key financial covenant being a consolidated leverage ratio test.
- 7The credit facility is guaranteed by several wholly-owned subsidiaries of IDEXX.